The transVaginal Mesh was introduced in the mid-1990’s. The transvaginal mesh was originally considered a major breakthrough for the treatment of pelvic organ prolapse (POP) occurring in women after childbirth, menopause, or hysterectomy. POP occurs when ligaments inside the pelvis or vaginal wall become stretched, making the uterus press on the bladder. This resulted in incontinence.The surgical mesh would relieve the resulting incontinence. Huge numbers patients who have been treated with the surgical mesh are facing devastating injuries as a result of erosion of the mesh into their vaginal wall. As a result, women are facing not only multiple revision surgeries to correct the problem, as well as mesh removal. Many women are left with pieces of the mesh in theor pelvic bone.
Get Help Today
Comments or questions are welcome.
There has been an FDA Warning issued on the Transvaginal Mesh,
Surgical Mesh, Prolapse Mesh, and other Mesh products
On July 13, 2011, the FDA issued a press release stating that transvaginal placement of surgical mesh to treat POP may carry more risk than other surgical options. The administration warned that vaginal mesh had been conclusively linked to a number of adverse events including:
- erosion through the vaginal wall
- pain during sexual intercourse
- urinary problems
- organ perforation
These side effects are resulting in additional surgeries,inability to sit, have sexual intercourse,drive,denial of enjoyments of life and severe physical and emotional complications.
The Pelvic Mesh Lawsuits Are Moving Along In A Multi District Litigation
Vaginal Mesh Multi District Lawsuit List Consolidated Under Judge Goodwin in West Virginia
MDL – 2325, IN RE: American Medical Systems, Inc., Pelvic Repair System Products Liability Litigation
MDL No. 2187 | In RE: CR Bard, Inc., Pelvic Repair System Products Liability Litigation
MDL – 2326 IN RE: Boston Scientific Corp. Pelvic Repair System Products Liability Litigation
MDL – 2327 IN RE: Ethicon, Inc., Pelvic Repair System Products Liability Litigation
MDL – 2387 IN RE: Coloplast Corp. Pelvic Support Systems Products Liability Litigation
Cook Medical Surgical will be the 5th MDL
Four of the manufacturers are ready to discuss a proposed settlement